加替沙星与左氧氟沙星治疗泌尿系统感染的经济学分析  

Pharmacoeconomic analysis of gatifloxacin and levofloxacin in the treatment of urinary system infection

作　　者：梁燕芳[1] 孔令瑞[1] 邓雪媚[1] 

机构地区：[1]肇庆市第一人民医院,广东肇庆526021

出　　处：《中国医药导报》2007年第08S期29-30,共2页China Medical Herald

摘　　要：目的:比较加替沙星与左氧氟沙星治疗泌尿系统感染的成本-效果分析。方法:采用药物经济学原理对两种治疗方案进行成本-效果分析。结果:加替沙星组与左氧氟沙星组治疗泌尿系统感染的有效率分别为93.75%、87.50%(P>0.05);不良反应发生率分别为6.3%、8.3%(P>0.05);成本-效果比(C/E)分别为8.75、4.31。与左氧氟沙星组相比,加替沙星组每增加一个单位效果需多花费70.91元。结论:左氧氟沙星治疗泌尿系统感染的成本-效果比优于加替沙星。Objective： To compare the cost-effectiveness ratio of gatifloxacin and levofloxacin in the treatment of patients with infection in urinary system. Methods： Principle of pharmacoeconomics was adopted to analyze the cost-effectiveness of two treatment schemes. Results： The effective rates of gatifloxacin group and levofloxacin group in the treatment of urinary system infection were 93.75% and 87.50% （P〉0.05） respectively;the incidence rates of adverse reactions were 6.3% and 8.3%（P〉0.05） ;The cost-effectiveness ratios （C/E） were 8.75 and 4.31 respectively. The cost for every one unit increment of effectiveness for gatifloxacin group was 70.91 Yuan more than that of the levofloxacin group. Conclusion： The cost-effectiveness ratio of levofloxacin is superior to that of gatifloxacin in the treatment of urinary system infection.

关 键 词：加替沙星 左氧氟沙星 泌尿系统感染 成本-效果分析 

分 类 号：R956[医药卫生—药学]